Quick answers
- What is Betamethasone valerate used for?
- The FDA-approved label (Betamethasone Valerate, Preferred Pharmaceuticals Inc., March 19, 2026) says: “Topical corticosteroids are indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.” This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or change any medicine.
- Does Betamethasone valerate have a boxed warning?
- No. None of the 19 FDA labels we found for this medicine has a boxed warning.
- Is there a shortage of Betamethasone valerate?
- No current shortage is listed by the FDA for the products of this medicine (FDA data from October 30, 2026).
- Has Betamethasone valerate been recalled?
- No recall linked to the products of this medicine appears in the FDA enforcement reports we use.
- Who makes Betamethasone valerate?
- 11 companies list prescription products of Betamethasone valerate in the FDA NDC Directory, including A-S Medication Solutions, E. Fougera & Co. a division of Fougera Pharmaceuticals, LLC and Preferred Pharmaceuticals Inc..
What Betamethasone valerate is used for
Quoted from the “Indications and Usage” section of the FDA-approved label.
Topical corticosteroids are indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.
— FDA label: Betamethasone Valerate, Preferred Pharmaceuticals Inc., effective March 19, 2026. Read the full label on DailyMed →
The FDA has 19 labels for products of this medicine (different makers and forms); uses can differ between them. Check the label that comes with your own medicine.
This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or change any medicine.
Boxed warning
A boxed warning (“black box”) is the FDA’s strongest warning on a drug label, for serious or life-threatening risks.
The label quoted above has no boxed warning.
0 of 19 FDA labels for this medicine have a boxed warning.
Forms and how it is given
| Dosage forms | Cream · Aerosol, foam · Ointment · Lotion |
|---|---|
| Route | Topical |
| Prescription products | 22 in the FDA NDC Directory |
What pharmacies pay (NADAC)
The National Average Drug Acquisition Cost (NADAC) is the average price U.S. retail pharmacies paid to buy one unit of a medicine (one tablet, one mL or one gram), from a monthly survey of pharmacy invoices by the Centers for Medicare & Medicaid Services (CMS). State Medicaid programs use it to pay pharmacies.
This is not the price you pay. What you pay depends on your insurance (copay or coinsurance), your pharmacy and any discounts, and pharmacies also charge for filling a prescription. Ask your pharmacist or your health plan what your price will be.
| Strength and form | Generic or brand | Pharmacies pay |
|---|---|---|
| betamethasone valerate 0.1% cream | Generic | $0.3527–$0.4337 per gram 4 packages, lowest to highest |
| betamethasone valerate 0.1% ointment | Generic | $0.4836–$0.5536 per gram 2 packages, lowest to highest |
| betamethasone valerate 0.12% aerosol, foam | Generic | $0.6289–$0.6770 per gram 8 packages, lowest to highest |
| betamethasone valerate 0.12% cream | Generic | $0.3527–$0.4337 per gram 2 packages, lowest to highest |
| betamethasone valerate 0.12% ointment | Generic | $0.4836–$0.5536 per gram 2 packages, lowest to highest |
| betamethasone valerate 1 mg/mL lotion | Generic | $0.4661 per mL |
NADAC list of November 4, 2026; these prices took effect on October 21, 2026. Shown only where a package’s NDC code matches the NADAC list exactly, and only for that exact strength and form: nothing is averaged across strengths. Strengths and forms not listed here have no NADAC price.
Source: NADAC (National Average Drug Acquisition Cost) 2026, data.medicaid.gov (CMS) →
Companies that list this medicine
Labelers in the FDA NDC Directory: the company named on the package (maker or distributor), with the number of prescription products.
- A-S Medication Solutions4 products
- E. Fougera & Co. a division of Fougera Pharmaceuticals, LLC3 products
- Preferred Pharmaceuticals Inc.3 products
- Sun Pharmaceutical Industries, Inc.2 products
- NuCare Pharmaceuticals, Inc.2 products
- Cosette Pharmaceuticals, Inc.2 products
- Proficient Rx LP2 products
- Padagis Israel Pharmaceuticals Ltd1 product
- Xiromed, LLC1 product
- Alembic Pharmaceuticals Limited1 product
- Alembic Pharmaceuticals Inc.1 product
FDA approval history
- NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
- ANDA: Abbreviated New Drug Application: how a generic version is approved.
| Application | Sponsor | Approved | Later changes approved |
|---|---|---|---|
| NDA018642 BETA-VAL | Cosette Pharms Nc | March 24, 1983 | 19, latest November 22, 2016 2016: Manufacturing (CMC) · 2001: Manufacturing (CMC) · 2000: Manufacturing (CMC) |
| NDA018861 BETAMETHASONE VALERATE | Fougera | August 31, 1983 | 9, latest December 4, 1997 1997: Manufacturing (CMC) · 1996: Labeling · 1996: Manufacturing (CMC) |
| NDA018865 BETAMETHASONE VALERATE | Fougera | August 31, 1983 | 8, latest January 20, 2015 2015: Manufacturing (CMC) · 1996: Labeling · 1996: Manufacturing (CMC) |
| NDA018866 BETAMETHASONE VALERATE | Fougera | August 31, 1983 | 8, latest March 24, 2014 2014: Manufacturing (CMC) · 1996: Labeling · 1995: Manufacturing (CMC) |
Generic approvals (6)
- ANDA070069Cosette Pharms Nc · December 19, 1985
- ANDA072041Sun Pharma Canada · January 6, 1988
- ANDA078337Padagis Israel · November 26, 2012
- ANDA208204Taro · May 24, 2017
- ANDA210639Xiromed · April 18, 2023
- ANDA215832Alembic · August 22, 2024
Shortage status
The FDA drug shortage list does not show these products.
Recalls
No recall linked to these products (by their NDC code) appears in the FDA enforcement reports.
Official identifiers
| RxCUI (RxNorm) | 197407, 197408, 197409, 1244634 |
|---|---|
| SPL set ID of the quoted label | 50d4763d-5a84-4c45-be06-040c4a527470 |
| FDA labels (SPL) | 19 |
| FDA applications | NDA018642, NDA018861, NDA018865, NDA018866, 6 ANDA |
| Active ingredients (FDA) | BETAMETHASONE VALERATE |
Sources
- FDA-approved label on DailyMed (National Library of Medicine) — Betamethasone Valerate, Preferred Pharmaceuticals Inc., effective March 19, 2026; via openFDA, FDA data exported October 30, 2026, retrieved October 31, 2026
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- Drug shortages (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
openFDA data is provided by the FDA as is; it may be incomplete. Always rely on the label that comes with your medicine. FDA Enforcement Report search →